Compare TRUP & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRUP | PLSE |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2014 | 2015 |
| Metric | TRUP | PLSE |
|---|---|---|
| Price | $25.67 | $19.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $44.50 | $22.00 |
| AVG Volume (30 Days) | ★ 313.9K | 253.6K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 295.65 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $1,439,305,000.00 | N/A |
| Revenue This Year | $12.48 | $840.00 |
| Revenue Next Year | $9.39 | $287.54 |
| P/E Ratio | $56.64 | ★ N/A |
| Revenue Growth | ★ 11.95 | N/A |
| 52 Week Low | $24.32 | $12.56 |
| 52 Week High | $57.35 | $26.30 |
| Indicator | TRUP | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 42.34 |
| Support Level | $24.80 | $13.75 |
| Resistance Level | $27.07 | $20.40 |
| Average True Range (ATR) | 1.01 | 1.57 |
| MACD | 0.19 | -0.27 |
| Stochastic Oscillator | 47.09 | 10.35 |
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.